COX-2 overexpression in peritoneal lesions is correlated with nonmenstrual chronic pelvic pain
article
OA: closed
CC0
⤵ 27 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study found that increased cyclooxygenase-2 expression in peritoneal lesions correlates with the presence of nonmenstrual chronic pelvic pain.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (29)
- 6 Classification of endometriosis via openalex
- 8 Endometriosis-associated infertility via openalex
- Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters via openalex
- Classification of endometriotic implants by morphologic appearance and capacity to synthesize prostaglandin F via openalex
- Conscious pain mapping by laparoscopy in women with chronic pelvic pain via openalex
- Correlation between endometriosis and pelvic pain via openalex
- COX-2 Inhibitors and Their Role in Gynecology via openalex
- Deep infiltrating endometriosis: relation between severity of dysmenorrhoea and extent of disease via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness via openalex
- Endometriosis-associated infertility via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Evaluation of the correlation between endometriosis extent, age of the patients and associated symptomatology. via openalex
- Expression of transforming growth factor β1 in nerve fibers is related to dysmenorrhea and laparoscopic appearance of endometriotic implants via openalex
- Impact of Surgical Resection of Rectovaginal Pouch of Douglas Endometriotic Nodules on Pelvic Pain and Some Elements of Patients' Sex Life via openalex
- W2024425168 via openalex
- W2023595441 via openalex
- W2148122132 via openalex
- W1975676198 via openalex
- W2155438634 via openalex
- W1969169755 via openalex
- W2347177325 via openalex
- W2401134385 via openalex
- W1561881745 via openalex
- W2409682597 via openalex
- W6604214559 via openalex
- W2061303223 via openalex
- W6681761019 via openalex
- W2054277979 via openalex
Cited by (27)
- Homozygous C677T Methylenetetrahydrofolate Reductase (MTHFR) Polymorphism as a Risk Factor for Endometriosis: A Retrospective Case–Control Study 2023
- Anti-endometriotic Effects of Ceratonia Siliqua L. Pod on Endometrial Mesenchymal Stromal/stem Cells Isolated from Women with Endometriosis-associated Infertility 2021
- Higher fibrotic content of endometriotic lesions is associated with diminished prostaglandin E2 signaling 2021
- Changing prostaglandin E2 (PGE<sub>2</sub>) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE<sub>2</sub> receptor EP2 and EP4 2021
- Could DNA hydroxymethylation be crucial in influencing steroid hormone signaling in endometrial biology and endometriosis? 2019
- Anti-angiogenic treatment of endometriosis via anti-VEGFA siRNA delivery by means of peptide-based carrier in a rat subcutaneous model 2018
- Pathogenetic aspects of treatment of patients with genital endometriosis and syndrome of chronic pelvic pain in combination with "proliferative genital syndrome". 2018
- The promising role of placental growth factor in association with cyclooxygenase-2 as predictive markers for recurrent ovarian endometriosis 2017
- Redox regulation of microRNAs in endometriosis-associated pain 2017
- Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions 2017
- DNA methylation in endometriosis (Review) 2016
- Oxidation-sensitive nociception involved in endometriosis-associated pain 2015
- Anti-inflammatory, antiangiogenic, and apoptosis-inducing activity of DLBS1442, a bioactive fraction of Phaleria macrocarpa, in a RL95-2 cell line as&nbsp;a&nbsp;molecular model of endometriosis 2015
- Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor- by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions 2014
- Role of Nerve Fibres in Endometriosis 2014
- Recent Advances in Gene Therapy of Endometriosis 2014
- Chronic Pelvic Pain in Endometriosis: An Overview 2013
- Recurrence of endometriosis; risk factors, mechanisms and biomarkers; review of the literature 2013
- The Epigenetics of Endometriosis 2012
- Histone deacetylase inhibitors as therapeutics for endometriosis 2012
- Therapeutic potential of andrographolide for treating endometriosis 2012
- Hypoxia‐inhibited dual‐specificity phosphatase‐2 expression in endometriotic cells regulates cyclooxygenase‐2 expression 2011
- Pathogenesis: Epigenetics 2011
- Expression of COX-2 in Intestinal Endometriosis to: Tokyol C, et al. Int J Gynecol Pathol 2009;28:148–56 2010
- ORIGINAL ARTICLE: Leptin on Peritoneal Macrophages of Patients with Endometriosis 2009
- Cyclooxygenase-2 expression, Ki-67 labeling index, and perifocal neovascularization in endometriotic lesions 2009
- Cyclooxygenase-2 overexpression in ovarian endometriomas is associated with higher risk of recurrence 2008
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:15:29.922408+00:00
License: CC0
· commercial use OK